ArticlePeerJ2021

Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II-III breast cancer patients using CytoSorter

Lidan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.